Carmen D. Herling

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity.

Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity.

Journal: Bone marrow transplantation
Published: April 26, 2026

Low muscle quality, but not muscle mass, in abdominal CT-scans associates with adverse outcomes in AML patients undergoing an allogeneic stem cell transplantation.

Low muscle quality, but not muscle mass, in abdominal CT-scans associates with adverse outcomes in AML patients undergoing an allogeneic stem cell transplantation.

Journal: Bone marrow transplantation
Published: April 11, 2026

We included a total of 87 patients who received CAR T-cell therapy: 54 with none/mild chronic kidney disease (CKD) and 33 with moderate/severe CKD.

We included a total of 87 patients who received CAR T-cell therapy: 54 with none/mild chronic kidney disease (CKD) and 33 with moderate/severe CKD.

Journal: Transplantation and cellular therapy
Published: February 10, 2026

Real-world experience with Tabelecleucel within and beyond the approval label.

Real-world experience with Tabelecleucel within and beyond the approval label.

Journal: Blood advances
Published: December 02, 2025

Real-world experience with tabelecleucel within and beyond the approval label.

Real-world experience with tabelecleucel within and beyond the approval label.

Journal: Blood advances
Published: December 02, 2025

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel.

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel.

Journal: Leukemia
Published: October 14, 2025

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.

Journal: HemaSphere
Published: September 11, 2025

The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation.

The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation.

Journal: Bone marrow transplantation
Published: July 22, 2025

Development and early feasibility testing of machine-learning algorithms to non-invasively assess hemoglobin levels.

Development and early feasibility testing of machine-learning algorithms to non-invasively assess hemoglobin levels.

Journal: npj biomedical innovations
Published: July 12, 2025

Total thrombus formation analysis in patients with myeloid neoplasia and thrombocytopenia.

Total thrombus formation analysis in patients with myeloid neoplasia and thrombocytopenia.

Journal: Annals of hematology
Published: June 26, 2025

Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells.

Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells.

Journal: Transfusion
Published: May 19, 2025

A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma.

A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma.

Journal: Cancer cell
Published: May 05, 2025
Showing 1-12 of 50

Last Updated: 09/26/2026